Evidence map›Paper›PMID 22187141›Full record

ArticleJournal of computer-aided molecular design2012

Does your model weigh the same as a duck?

Ajay N Jain, Ann E Cleves

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. The Lateral Metalation of Isoxazolo[3,4-Molecules (Basel, Switzerland) · 2023
    Article
  3. Can Machine Learning Predict the Phase Behavior of Surfactants?The journal of physical chemistry. B · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Extrapolative prediction using physically-based QSAR.Journal of computer-aided molecular design · 2016
    Article
  9. Article
  10. Prediction of off-target drug effects through data fusion.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2014
    Article
  11. Article
  12. On exploring structure-activity relationships.Methods in molecular biology (Clifton, N.J.) · 2013
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ajay N JainDepartment of Bioengineering and Therapeutic Sciences, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158-9001, USA. ajain@jainlab.org
Ann E Cleves

Funding

Machine Learning in Chemistry and BiologyR01GM070481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2005 to 2013
$2.5M
Binding-Site Modeling with Multiple-Instance Machine-LearningR01GM101689 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2013 to 2020
$2.4M
NIGMS NIH HHS GM070481NIGMS NIH HHS R01 GM070481NIGMS NIH HHS R01 GM101689
6 · The paper itself

Abstract

Computer-aided drug design is a mature field by some measures, and it has produced notable successes that underpin the study of interactions between small molecules and living systems. However, unlike a truly mature field, fallacies of logic lie at the heart of the arguments in support of major lines of research on methodology and validation thereof. Two particularly pernicious ones are cum hoc ergo propter hoc (with this, therefore because of this) and confirmation bias (seeking evidence that is confirmatory of the hypothesis at hand). These fallacies will be discussed in the context of off-target predictive modeling, QSAR, molecular similarity computations, and docking. Examples will be shown that avoid these problems.

Indexed as

Drug DesignModels, MolecularProtein BindingQuantitative Structure-Activity RelationshipComputer-Aided DesignHumansInformaticsLigandsLigands

Identifiers

PMID22187141
PMCPMC3276372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.